Allyson McMillan-Youngblood
ALLYSON McMILLAN-YOUNGBLOOD has been in the bio-pharma industry and healthcare space for over 25 years. She is currently at Bristol Myers Squibb (BMS) where she has had several roles of increasing responsibility across medical devices, oncology, cardiovascular-metabolics and immunology. She is currently senior vice president and US head for BMS oncology where she is responsible for overseeing the company oncology portfolio of over $7bn and more than 400 people across five key solid tumor cancer brands. Prior to joining BMS, McMillan-Youngblood had brand management roles at Procter & Gamble, Schering-Plough OTC, and sales roles at Pfizer, Inc. She has had an impressive track record of re-shaping business challenges and driving results with deep experience in both HCP and patient marketing. She is known as a dynamic leader who builds strong teams and drives impactful change. McMillan-Youngblood and her husband are extremely active in the area and serve on multiple boards that support the community.